[Blood coagulation and fibrinolytic enzyme systems during and after extracorporeal circulation].
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000097:blood / Q000188:drug therapy / Q000201:enzymology* / Q000209:etiology; D001792:Blood Platelets; D002648:Child; D002675:Child, Preschool; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006330:Heart Defects, Congenital / Q000601:surgery; D006487:Hemostasis; D006801:Humans; D010958:Plasminogen / Q000032:analysis; D011516:Prothrombin / Q000032:analysis; D011517:Prothrombin Time
D000933:Antifibrinolytic Agents; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005340:Fibrinogen; D010958:Plasminogen
Das Blutgerinnungs- und das fibrinolytische Enzymsystem während und nach extrakorporalem Kreislauf.